These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21834046)

  • 21. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia.
    Bacalman S; Farzin F; Bourgeois JA; Cogswell J; Goodlin-Jones BL; Gane LW; Grigsby J; Leehey MA; Tassone F; Hagerman RJ
    J Clin Psychiatry; 2006 Jan; 67(1):87-94. PubMed ID: 16426093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
    González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
    Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening for fragile X syndrome. International experiences].
    Vuust J; Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3704-9. PubMed ID: 17069733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
    Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
    Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of population screening for fragile X syndrome.
    Hill MK; Archibald AD; Cohen J; Metcalfe SA
    Genet Med; 2010 Jul; 12(7):396-410. PubMed ID: 20548240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS).
    Adams JS; Adams PE; Nguyen D; Brunberg JA; Tassone F; Zhang W; Koldewyn K; Rivera SM; Grigsby J; Zhang L; DeCarli C; Hagerman PJ; Hagerman RJ
    Neurology; 2007 Aug; 69(9):851-9. PubMed ID: 17724287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of Fragile X-associated tremor/ataxia syndrome (FXTAS).
    Mishra SK; Khosa S; Trikamji B; Khanli HM; Scheuner MT; Jamal NI; Hanssen AM
    J Clin Neurosci; 2019 Aug; 66():269-270. PubMed ID: 31178302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fragile X testing in obstetrics and gynaecology in Canada.
    Chitayat D; Wyatt PR; ;
    J Obstet Gynaecol Can; 2008 Sep; 30(9):837-841. PubMed ID: 18845054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heterogeneity of clinical characteristics of FMR1-related disorders].
    Pereverzeva DS; Tyushkevich SA; Gorbachevskaya NL; Mamokhina UA; Danilina KK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):103-111. PubMed ID: 31464297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axonal neuropathy in female carriers of the fragile X premutation with fragile x-associated tremor ataxia syndrome.
    Ram S; Devapriya IA; Fenton G; Mcvay L; Nguyen DV; Tassone F; Maselli RA; Hagerman RJ
    Muscle Nerve; 2015 Aug; 52(2):234-9. PubMed ID: 25388402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Testing Practices of Genetic Counselors, Geneticists, and Pediatric Neurologists With Regard to Childhood-Onset Neurogenetic Conditions.
    Wofford S; Noblin S; Davis JM; Farach LS; Hashmi SS; Mancias P; Wagner VF
    J Child Neurol; 2019 Mar; 34(4):177-183. PubMed ID: 30608006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes Toward Discussing Approved and Investigational Treatments for Cystic Fibrosis in Prenatal Genetic Counseling Practice.
    Elsas CR; Schwind EL; Hercher L; Smith MJ; Young KG
    J Genet Couns; 2017 Feb; 26(1):63-71. PubMed ID: 27277131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.
    Ryynänen M; Kirkinen P; Mannermaa A; Saarikoski S
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1236-9. PubMed ID: 7726262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.
    Cronister A; DiMaio M; Mahoney MJ; Donnenfeld AE; Hallam S
    Genet Med; 2005 Apr; 7(4):246-50. PubMed ID: 15834242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal genetic counseling: what is fragile X?
    Bodurtha J; Tams L; Jackson-Cook C
    Va Med Q; 1992; 119(2):97-8. PubMed ID: 1562624
    [No Abstract]   [Full Text] [Related]  

  • 38. A five-year experience with fragile X screening of high-risk gravid women.
    Wenstrom KD; Descartes M; Franklin J; Cliver SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):789-92. PubMed ID: 10521730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice.
    Suskin E; Hercher L; Aaron KE; Bajaj K
    J Genet Couns; 2016 Oct; 25(5):1032-43. PubMed ID: 26879922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for fragile X.
    Berry AC
    J Med Screen; 1997; 4(4):247. PubMed ID: 9494916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.